Meditech Health Automation Ltd - Accounts to registrar (filleted)

REGISTERED NUMBER: 15978376 (England and Wales)

Financial Statements

for the Period 25 September 2024 to 31 December 2025

for

Meditech Health Automation Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

J D Clement

SECRETARY:

MY UK OFFICE LIMITED

REGISTERED OFFICE:

Westwood House

Annie Med Lane

South Cave

HU15 2HG

REGISTERED NUMBER:

15978376 (England and Wales)

AUDITORS:

Try Lunn & Co

Chartered Accountants and Registered Auditors

Roland House

Princes Dock Street

Hull

HU1 2LD

FIXED ASSETS

Tangible assets

4

3,422,104

CURRENT ASSETS

Debtors

5

698,606

Cash at bank

206,847

905,453

CREDITORS

Amounts falling due within one year

6

4,492,177

NET CURRENT LIABILITIES

(3,586,724

)

TOTAL ASSETS LESS CURRENT
LIABILITIES

(164,620

)

CAPITAL AND RESERVES

Called up share capital

7

100

Retained earnings

8

(164,720

)

SHAREHOLDERS' FUNDS

(164,620

)

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 June 2026 and were signed by:

J D Clement - Director

1.	STATUTORY INFORMATION

Meditech Health Automation Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company is dependent on the parent company Pharmatechnik Unternehmensberatung S.A. for operational and financial support. The directors of Pharmatechnik Unternehmensberatung S.A. have confirmed their agreement to provide this support for a period of at least 12 months from the date of the signing of the financial statements of Meditech Health Automation Ltd. On this basis the financial statements have been prepared on the going concern basis.

Turnover

Turnover comprises fees in respect of rental of machinery. Revenue is recognised on a monthly basis, evenly over the rental period.

Turnover is recognised net of VAT and trade discounts.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold Property - 2% on cost

Plant & Machinery - Straight line over 12 years

Improvements to property - 10% on cost

Fixtures & Fittings - 20% on cost

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

Freehold

to

Plant and

and

property

machinery

fittings

Totals

£

COST

Additions

2,326,663

437,758

740,998

1,060

3,506,479

At 31 December 2025

2,326,663

437,758

740,998

1,060

3,506,479

DEPRECIATION

Charge for period

27,920

22,188

33,998

269

84,375

At 31 December 2025

27,920

22,188

33,998

269

84,375

NET BOOK VALUE

At 31 December 2025

2,298,743

415,570

707,000

791

3,422,104

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Other debtors

3,471

VAT

675,962

Prepayments

19,173

698,606

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Trade creditors

34,617

Amounts owed to group undertakings

4,443,758

Accruals and deferred income

13,802

4,492,177

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

value:

£

100

Ordinary

£1

100

8.

RESERVES

Retained

earnings

£

Deficit for the period

(164,720

)

At 31 December 2025

(164,720

)

9.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Andrew Ewart FCCA FCA (Senior Statutory Auditor)

for and on behalf of Try Lunn & Co

10.	RELATED PARTY DISCLOSURES

During the year the parent company Pharmatechnik Unternehmensberatung S.A. loaned £3,999,525 to Meditech Health Automation Ltd for working capital. The company repaid £721,192 during the year. At the balance sheet date the amount owed to Pharmatechnik Unternehmensberatung S.A. was £3,278,333. This loan is interest free and payable on demand.

During the year 4GC Ltd, a company under common control, loaned £865,470 to Meditech Health Automation Ltd for working capital. At the balance sheet date the amount owed to 4GC Ltd was £865,470. This loan is interest free and payable on demand.

During the year the company purchased goods totalling £10,996 from Pharmatechnik Unternehmensberatung S.A. At the balance sheet date £10,996 was owed to Pharmatechnik Unternehmensberatung S.A.

During the year the company purchased fixed assets totalling £740,998 from A.C.N BV, a company under common control. At the balance sheet date the amount owed to A.C.N BV was £288,959.

During the year the company purchased fixed assets totalling £12,758 from H Retail, a company under common control. At the balance sheet date no amounts were due to H Retail.

11.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party is J D Clement.